Physician profile
Eric T Lee
NPI 1619104924
$13,819.21
in general payments reported to CMS, 2019-2025
67 companies · $3,201 in 2025
The $3,201 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,569 · 2020: $1,136 · 2021: $527 · 2022: $2,183 · 2023: $2,551 · 2024: $2,653 · 2025: $3,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,351 · Education: $53.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,350.56 |
| Education | $53.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $756.50 | 2019-2025 | |
| Lilly USA, LLC | $749.20 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Abbvie INC. | $685.15 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $682.32 | 2019-2025 | Ultomiris, Soliris |
| Emd Serono, INC. | $664.52 | 2019-2025 | Mavenclad |
| Pfizer INC. | $637.47 | 2023-2025 | |
| Genzyme Corporation | $599.97 | 2019-2025 | |
| Abbott Laboratories | $539.19 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $452.44 | 2019-2025 | Nuplazid |
| Argenx US, INC. | $430.38 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Ucb, INC. | $413.64 | 2020-2025 | Rystiggo, Briviact, Zilbrysq |
| Amgen INC. | $377.66 | 2019-2024 | Uplizna |
| Teva Pharmaceuticals USA, INC. | $373.61 | 2019-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $347.68 | 2019-2025 | Rexulti |
| Sk Life Science, INC. | $346.46 | 2020-2025 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $337.39 | 2023-2025 | |
| Merz Pharmaceuticals, LLC | $328.98 | 2022-2025 | Xeomin, Inbrija |
| Genentech USA, INC. | $301.55 | 2022-2025 | Ocrevus, Ocrevus Zunovo |
| Impel Pharmaceuticals INC. | $296.62 | 2022-2023 | Trudhesa |
| Neurelis, INC. | $272.92 | 2023-2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $266.50 | 2019-2025 | Rytary, Crexont |
| Acorda Therapeutics, INC | $250.04 | 2019-2024 | Inbrija, Ampyra |
| Biogen, INC. | $237.24 | 2019-2024 | Vumerity, Tysabri |
| Medtronic, INC. | $233.62 | 2023-2025 | Intellis Adaptivestim, Percept PC Brainsense |
| Alnylam Pharmaceuticals INC. | $230.82 | 2023-2025 | Amvuttra, Onpattro |
| Neurocrine Biosciences, INC. | $220.21 | 2019-2024 | Ingrezza, Ongentys |
| Csl Behring | $214.79 | 2019-2025 | Hizentra |
| Upsher-Smith Laboratories LLC | $164.46 | 2019-2022 | |
| Eisai INC. | $143.13 | 2024-2025 | |
| Baxter Healthcare | $141.51 | 2025 | Tisseel |
| Sumitomo Pharma America, INC. | $139.01 | 2023-2024 | Aptiom |
| Celgene Corporation | $122.95 | 2022-2025 | Zeposia |
| Biohaven Pharmaceutical Holding Company LTD. | $117.58 | 2022 | |
| Grifols USA, LLC | $111.23 | 2019-2020 | |
| Janssen Biotech, INC. | $110.24 | 2025 | |
| Jazz Pharmaceuticals INC. | $100.74 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $94.87 | 2022 | |
| Amylyx Pharmaceuticals, INC. | $93.39 | 2023 | Relyvrio |
| Sunovion Pharmaceuticals INC. | $91.78 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $79.83 | 2024-2025 | Dysport |
| Otsuka America Pharmaceutical, INC. | $75.61 | 2023-2024 | Rexulti, Nuedexta |
| Catalyst Pharmaceuticals, INC. | $72.47 | 2019-2022 | |
| Mdd US Operations, LLC | $69.83 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $68.21 | 2025 | Hyqvia |
| Azurity Pharmaceuticals, INC. | $62.99 | 2023-2024 | Horizant, Horizant |
| Kyowa Kirin, INC. | $62.60 | 2020 | |
| Ge Healthcare | $60.49 | 2019-2025 | |
| Avanir Pharmaceuticals, INC. | $57.20 | 2019-2022 | |
| Avion Pharmaceuticals | $52.72 | 2022 | |
| Allergan, INC. | $47.73 | 2019-2021 | |
| Bausch Health US, LLC | $45.60 | 2019-2020 | |
| Livanova USA, INC. | $44.19 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic USA, INC. | $43.23 | 2019 | |
| Boston Scientific Corporation | $37.43 | 2019 | |
| Assertio Therapeutics, INC. | $31.86 | 2019 | |
| Adamas Pharmaceuticals, INC. | $22.70 | 2019 | |
| Cala Health, INC. | $22.51 | 2023 | Cala Trio |
| Vertical Pharmaceuticals, LLC | $21.11 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.09 | 2025 | |
| Banner Life Sciences, LLC | $19.97 | 2023 | |
| Novo Nordisk INC | $19.78 | 2025 | Wegovy |
| Springworks Therapeutics, INC. | $19.75 | 2025 | Gomekli |
| Horizon Therapeutics Plc | $18.90 | 2023 | Uplizna |
| Xeris Pharmaceuticals, INC. | $18.86 | 2022 | |
| Itf Therapeutics LLC | $18.68 | 2024 | |
| Supernus Pharmaceuticals, INC. | $14.50 | 2019 | |
| Currax Pharmaceuticals LLC | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.